Introduction and objectives Guideline-defined asthma control may be achieved and
maintained in the majority of patients by treatment with a combination of a corticosteroid and …

Objective: To compare the clinical efficacy and safety of fluticasone/salmeterol (Flu/Salm)
combined in the new “Forspiro” DPI with Seretide Accuhaler (Glaxo Wellcome). Methods …

Background: Guideline-defined asthma control can be achieved and maintained in patients
by treatment with fluticasone propionate–salmeterol (FP-Sal). Objective: To compare the …

Methods: This comparative study, conducted in a population of 279 patients aged 12–65
years with GINA guideline-defined moderate-to-severe persistent asthma was undertaken …

Background The combination of fluticasone furoate (FF), a novel inhaled corticosteroid
(ICS), and vilanterol (VI), a long-acting β 2 agonist, is under development as a once-daily …

OBJECTIVE:: This study compared the efficacy andtolerability of the combination of
fluticasone propionate (FP) and salmeterol (SAL) delivered via a single hydrofluoroalkane …

Background To analyse the efficacy of fluticasone propionate (FP) alone and combined with
salmeterol (SAL) in achieving guideline-defined asthma control in Asian patients. Methods A …

Background Improvement of the delivery method of inhaled corticosteroids and subsequent
dose reduction can minimize the risk of unfavorable outcomes while providing optimal …

Our objective was to compare the efficacy and safety of formoterol (Foradil®) delivered via a
novel multidose dry powder inhaler (Certihaler™) with placebo and albuterol [pressurized …

Rationale: Limited data exist comparing inhaled corticosteroid (ICS) plus adjunctive therapy
(eg, a long-acting bronchodilator) and ICS monotherapy in paediatric patients with …